Author

Kristian Sandberg

Uppsala UniversityPrimary ORCID profile (0000-0001-6936-5487 · 11 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Kristian SandbergiD11 papers · Aarhus University

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:virus· 1

Frequent Co-Authors

Åke LundkvistiD· 1 shared Anja SandströmiD· 1 shared Dario AkaberiiD· 1 shared Emilia Strandback· 1 shared Grace NeilseniD· 1 shared Hjalmar Gullberg· 1 shared Janina KrambrichiD· 1 shared Johan LennerstrandiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Åke LundkvistORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of unique and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries

Dario Akaberi, Monireh Pourghasemi Lati, Janina Krambrich, Julia Berger, Grace Neilsen, Emilia Strandback, S. Pauliina Turunen, Johan Wannberg, Hjalmar Gullberg, Martin Moche, Praveen Kumar Chinthakindi, Tomas Nyman, Stefan G. Sarafianos, Anja Sandström, Josef D. Järhult, , Johan Lennerstrand

This paper identifies potent SARS-CoV-2 main protease inhibitors from a DNA-encoded chemical library using affinity-based selection, achieving an IC50 of 30 nM for compound SLL11.

Antimicrobial Agents and Chemotherapy · Aug 28, 2024Peer-reviewedMicrobiology